Guardian Pharmacy Services Stock
Guardian Pharmacy Services, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Country
- United States
- CEO
- Fred Burke
- Employees
- 3,600
- Market cap
- $2.5 B
- IPO
- 26/09/2024
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider that delivers an extensive array of tech-driven solutions. The company is based in Atlanta and was established in 2003. Its business model focuses on enhancing the care of residents within long-term health care facilities (LTCFs) across the…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Guardian Pharmacy Services stock: price history
1D
-0.5%
1W
-4.4%
1M
-15.2%
6M
+5.1%
YTD
+31.2%
1Y
+62.0%
2Y
+120.0%
5Y
–
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~47% stronger price swings than usual
Ask the agents about Guardian Pharmacy Services
Analyst assessment of Guardian Pharmacy Services
PRICE TARGET LOW
US$49.00
CONSENSUS
US$50.67
MEDIAN
US$51.00
PRICE TARGET HIGH
US$52.00
0
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 21/09/2026
Guardian Pharmacy Services stock metrics
P/E
37.59
P/B
10.18
EV/EBITDA
20.4
RETURN ON EQUITY
8.9%
NET MARGIN
6.2%
DEBT/EQUITY
0.14
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
80.7%
FLOAT SHARES
51,117,294
AVG. DAILY VOLUME (30D)
637,886
Insider transactions (SEC)
Mudd William Franklin
Ackerman John
Ackerman John
Weir Robert
Towns Douglas
Institutional holders
Comparable stocks
Frequently asked questions about Guardian Pharmacy Services stock
What does Guardian Pharmacy Services do?
Guardian Pharmacy Services, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.
The CEO is Fred Burke, the company employs around 3,600 people.
The IPO was on 26/09/2024; the stock trades on NYSE under the ticker GRDN.
What do analysts say about Guardian Pharmacy Services stock?
4 analysts rate the stock, the consensus is Buy (as of 21/09/2026).
The average price target is US$50.67, ranging from US$49.00 to US$52.00, with a median of US$51.00.
This is an external assessment, not a statement by Market Jury.
When does Guardian Pharmacy Services report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 47% stronger than usual.
Does Guardian Pharmacy Services pay a dividend?
No, Guardian Pharmacy Services currently does not pay a dividend.
Which stocks are comparable to Guardian Pharmacy Services?
Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.
How can I get Guardian Pharmacy Services stock analyzed?
Clicking "Analyze stock" lets five strategies assess Guardian Pharmacy Services against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.